"Bronchoconstriction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Narrowing of the caliber of the BRONCHI, physiologically or as a result of pharmacological intervention.
Descriptor ID |
D016084
|
MeSH Number(s) |
G09.772.705.700.080
|
Concept/Terms |
Bronchoconstriction- Bronchoconstriction
- Bronchoconstrictions
- Bronchial Constriction
- Bronchial Constrictions
- Constriction, Bronchial
- Constrictions, Bronchial
|
Below are MeSH descriptors whose meaning is more general than "Bronchoconstriction".
Below are MeSH descriptors whose meaning is more specific than "Bronchoconstriction".
This graph shows the total number of publications written about "Bronchoconstriction" by people in this website by year, and whether "Bronchoconstriction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2017 | 2 | 2 | 4 |
2018 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Bronchoconstriction" by people in Profiles.
-
Age-related gene expression alterations by SARS-CoV-2 infection contribute to poor prognosis in elderly. J Genet. 2020; 99.
-
ß2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseases. Curr Opin Pharmacol. 2018 06; 40:142-146.
-
Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapy. Curr Opin Pharmacol. 2018 06; 40:95-103.
-
Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways. J Vet Pharmacol Ther. 2018 Aug; 41(4):546-554.
-
Solitary Cholinergic Stimulation Induces Airway Hyperreactivity and Transcription of Distinct Pro-inflammatory Pathways. Lung. 2018 04; 196(2):219-229.
-
Realising the potential of various inhaled airway challenge agents through improved delivery to the lungs. Pulm Pharmacol Ther. 2018 04; 49:27-35.
-
Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD. Lung. 2018 02; 196(1):15-18.
-
Hypoxic Pulmonary Vasoconstriction Does Not Explain All Regional Perfusion Redistribution in Asthma. Am J Respir Crit Care Med. 2017 10 01; 196(7):834-844.
-
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma. Eur Respir J. 2017 09; 50(3).
-
The TLR4-TRIF pathway can protect against the development of experimental allergic asthma. Immunology. 2017 09; 152(1):138-149.